Invention Grant
- Patent Title: Thieno-pyridine derivatives as MEK inhibitors
-
Application No.: US12691842Application Date: 2010-01-22
-
Publication No.: US08350037B2Publication Date: 2013-01-08
- Inventor: James Andrew Johnson , Daniel Christopher Brookings , Martin Clive Hutchings , Barry John Langham , Judi Charlotte Neuss
- Applicant: James Andrew Johnson , Daniel Christopher Brookings , Martin Clive Hutchings , Barry John Langham , Judi Charlotte Neuss
- Applicant Address: BE Brussels
- Assignee: UCB Pharma, S.A.
- Current Assignee: UCB Pharma, S.A.
- Current Assignee Address: BE Brussels
- Agency: Feldman Gale, P.A.
- Agent Walter C. Frank
- Priority: GB0714384.5 20070723; WOPCT/GB2008/002430 20080716
- Main IPC: A61K31/4436
- IPC: A61K31/4436 ; C07D513/04
Abstract:
A series of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.
Public/Granted literature
- US20100179124A1 THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS Public/Granted day:2010-07-15
Information query
IPC分类:
